We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

180 hedge funds and large institutions have $2.77B invested in SpringWorks Therapeutics in 2023 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 78 increasing their positions, 34 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

330% more call options, than puts

Call options by funds: $29.4M | Put options by funds: $6.84M

165% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 20

129% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 34

125% more funds holding in top 10

Funds holding in top 10: 4 → 9 (+5)

75% more capital invested

Capital invested by funds: $1.58B → $2.77B (+$1.19B)

22% more funds holding

Funds holding: 147 → 180 (+33)

4.05% less ownership

Funds ownership: 109.42% → 105.37% (-4%)

Holders
180
Holders Change
+33
Holders Change %
+22.45%
% of All Funds
2.62%
Holding in Top 10
9
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+125%
% of All Funds
0.13%
New
53
Increased
78
Reduced
34
Closed
20
Calls
$29.4M
Puts
$6.84M
Net Calls
+$22.6M
Net Calls Change
+$22.8M

Top Buyers

Rank Fund Capital Flow
1
MC
Maverick Capital
Texas
+$58.3M
2
Marshall Wace
Marshall Wace
United Kingdom
+$45.3M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$42.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$37.2M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$31.9M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$80M
2
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$71.2M
3
BBA
Baker Bros. Advisors
New York
-$69.4M
4
O
OrbiMed
New York
-$19.6M
5
DCM
Driehaus Capital Management
Illinois
-$10.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
126
Oppenheimer Asset Management
New York
$379K -$33.1K -1,267 -11%
DA
127
Duality Advisers
Florida
$378K +$270K +10,362 New
Teacher Retirement System of Texas
128
Teacher Retirement System of Texas
Texas
$375K +$13K +498 +5%
First Trust Advisors
129
First Trust Advisors
Illinois
$370K +$264K +10,129 New
ACP
130
Acuta Capital Partners
California
$365K +$261K +10,000 New
BC
131
Birchview Capital
Vermont
$365K +$261K +10,000 New
AB
132
Amalgamated Bank
New York
$353K +$21K +805 +9%
VEA
133
Virtus ETF Advisers
New York
$343K +$152K +5,816 +162%
GCM
134
Graham Capital Management
Connecticut
$327K +$234K +8,964 New
NRD
135
Nebula Research & Development
New York
$323K +$231K +8,850 New
Zurich Cantonal Bank
136
Zurich Cantonal Bank
Switzerland
$316K +$62.3K +2,387 +38%
Verition Fund Management
137
Verition Fund Management
Connecticut
$285K +$204K +7,804 New
EFM
138
E Fund Management
China
$283K -$38.5K -1,474 -16%
PA
139
Parallel Advisors
California
$276K -$287 -11 -0.1%
SCA
140
Snowden Capital Advisors
New York
$276K +$197K +7,550 New
CUAMC
141
China Universal Asset Management Company
China
$264K +$147K +5,625 +349%
SSA
142
Sierra Summit Advisors
Nevada
$256K +$183K +7,022 New
AIP
143
Ameritas Investment Partners
Nebraska
$254K +$30.2K +1,158 +20%
CSS
144
Cubist Systematic Strategies
Connecticut
$253K +$181K +6,941 New
American Century Companies
145
American Century Companies
Missouri
$245K +$175K +6,706 New
BCM
146
Bayesian Capital Management
New York
$234K +$167K +6,398 New
Mariner
147
Mariner
Kansas
$220K +$157K +6,033 New
ETC
148
Exchange Traded Concepts
Oklahoma
$194K +$35.2K +1,350 +34%
TRCT
149
Tower Research Capital (TRC)
New York
$170K +$90.6K +3,470 +289%
Public Employees Retirement Association of Colorado
150
Public Employees Retirement Association of Colorado
Colorado
$167K – – –
4 5
6
7 8

SWTX Hedge Fund Activity: Q4 2023 in Review

180 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q4 2023, worth a combined $2.77B — up 75% from $1.58B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new SWTX positions and 20 closed out — a net gain of 33 holders — while 78 added to existing stakes and 34 trimmed.

The largest buyer was Maverick Capital, adding an estimated $58.3M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $80M sold.

  • 180 institutional investors held SpringWorks Therapeutics (SWTX) as of Q4 2023, up from 147 in Q3 2023.
  • Funds reported $2.77B of SpringWorks Therapeutics stock for Q4 2023, up 75% quarter-over-quarter.
  • 53 funds opened new SpringWorks Therapeutics positions in Q4 2023 and 20 closed out, a net change of +33 holders.
  • The largest SpringWorks Therapeutics buyer in Q4 2023 was Maverick Capital, an estimated $58.3M added.
  • The largest SpringWorks Therapeutics seller in Q4 2023 was EcoR1 Capital, an estimated $80M sold.

Based on aggregated 13F filings for Q4 2023.